ACUTAASNSEAcutaas Chemicals LimitedLowNeutral
Announced Fri, 2 May · 13:20 IST

Ami Organics Limited has informed the Exchange regarding Outcome of Board Meeting held on May 02, 2025.

Board & Shareholder Meetings View source PDF

ACUTAAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

The Board of Directors met on May 2, 2025 and approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2025. Consolidated revenue from operations for FY25 was Rs. 1,00,687.55 lakhs, up about 40% from Rs. 71,747.45 lakhs in FY24, while net profit jumped to Rs. 16,041.77 lakhs from Rs. 4,870.80 lakhs (the prior year figure was dragged down by a one-time exceptional loss of Rs. 3,208.39 lakhs). For Q4 FY25, consolidated revenue was Rs. 30,848.34 lakhs and net profit was Rs. 6,271.61 lakhs, both sharply higher year-on-year. The Board recommended a final dividend of Rs. 1.50 per share (30%) on the post-split face value of Rs. 5, subject to shareholder approval, and appointed M/s Chirag Vekariya & Co. as Cost Auditor for FY 2025-26. The filing also notes the ongoing name change to Acutaas Chemicals Limited and the 1:2 stock split (face value Rs. 10 to Rs. 5) with record date April 25, 2025.

Likely market impact

Strong revenue and profit growth, plus a dividend, are positive for shareholders. The balance sheet is materially stronger — cash and equivalents rose to Rs. 185 crore from Rs. 30 crore and borrowings have been largely repaid, thanks to the fully deployed QIP of Rs. 400 crore. However, about Rs. 31.5 crore of preferential issue funds remain unutilized, with the deployment deadline extended to March 2026.